معرفی
Simon Carding is a Professor of Mucosal Immunology at Norwich Medical School, University of East Anglia (UEA), and a Research Leader in the Gut Health and Food Safety (GHFS) Programme at the Institute of Food Research. He is also a member of the Norwich Institute for Healthy Aging. His work integrates mucosal immunology, gut microbiology, and host-microbe interactions to understand intestinal health and disease.
- PhD, MRC Clinical Research Centre, Harrow (1985)
- Visiting Instructor, NYU School of Medicine (1985–1986)
- Postdoctoral Associate & Howard Hughes Fellow, Yale University (1986–1991)
- Assistant/Associate Professor, University of Pennsylvania (1991–1999)
- Professor of Molecular Immunology, University of Leeds (1999–2008)
- Professor of Mucosal Immunology, UEA (2008–present)
His research centers on mucosal immunology, intestinal microbial tolerance, and the role of host-microbe crosstalk in health and diseases like inflammatory bowel disease (IBD). He investigates autophagy, epithelial barrier function, dendritic cell biology, and the development of engineered Bacteroides for therapeutic delivery. His group also explores immunosenescence, chronic fatigue syndrome, and gut-brain axis interactions.
The recent publications highlight a strong trend in bacterial extracellular vesicles, engineered probiotics, gut-brain translocation models, and functional assessment in chronic fatigue. His work often involves interdisciplinary approaches combining immunology, microbiology, bioengineering, and computational modeling.
- RCUK Grant Review and Advisory Panels (2000–)
- Grant reviewer for international funding bodies (2008–)
- Advisory boards for biomedical charities and industry (2000–)
- Invited speaker at national and international conferences (1990–)
- Reviewer for international journals (1986–)
Simon Carding has supervised postgraduate research students in gut biology, mucosal immunity, and microbiome-related fields. He has secured grants from BBSRC, Innovate UK, and Invest in ME, including projects on viral phagocytosis, chronic fatigue, and bacterial vesicle vaccines. He founded Ovatus Ltd., a spin-out company with UK and international patents, demonstrating strong enterprise engagement.
He leads the GHFS Programme, comprising 13 research groups and around 60 scientists, focusing on gut epithelial physiology, microbiome, immunity, and food safety. The programme integrates experimental and computational approaches to advance gut health research.
حوزههای پژوهشی
